Home Tags Drug Approvals

Tag: Drug Approvals

Even Five Years Postapproval, Many Drug Studies Remain Nonpublic

Authors urge greater transparency of study results for drugs approved by the FDA

First Biosimilar Approved to Treat Multiple Sclerosis

Tyruko, biosimilar to Tysabri (natalizumab) injection, approved for treatment of clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease

FDA Approves Akeega for BRCA-Positive Metastatic Prostate Cancer

Akeega plus prednisone significantly improves radiographic progression-free survival in patients with castration-resistant prostate cancer

FDA Provides Accelerated Approval of Talvey for Multiple Myeloma

Talvey, a bispecific therapy, indicated for the treatment of patients with relapsed, refractory, heavily pretreated multiple myeloma

FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration

Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point

FDA Gives Approval to Pill to Ease Postpartum Depression

Zurzuvae works faster than conventional antidepressants and is easier to take than another postpartum depression drug that is delivered intravenously

FDA Approves Xdemvy for Demodex Blepharitis

Significant improvements seen in reduction of collarettes in as early as two weeks

FDA Approves Topical Treatment for Molluscum Contagiosum

Ycanth approved for adults and children older than 2 years

FDA Approves New Drug to Protect Against RSV in Infants

A single injection of Beyfortus administered before or during RSV season can provide protection during the season

FDA Approves First Over-the-Counter Birth Control Pill

Women will be able to buy the progestin-only oral contraceptive at drug stores, convenience stores, and grocery stores